Motus GI Holdings, Inc.

Equities

MOTS

US62014P5044

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
0.439 USD +5.50% Intraday chart for Motus GI Holdings, Inc. -13.92% -65.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Earnings Flash (MOTS) MOTUS GI HOLDINGS Reports Q4 Revenue $64,000 MT
Motus GI Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Motus GI Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Transcript : Motus GI Holdings, Inc. - Shareholder/Analyst Call
Motus GI Holdings, Inc. Publishes Positive Results from A European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with A History of Poor Bowel Preparation CI
Top Midday Decliners MT
Looming Inflation Data Stifle US Equity Futures Pre-Bell MT
Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon MT
Motus GI Holdings Prices $5 Million Offering of Shares, Warrants MT
Top Premarket Decliners MT
Top Premarket Gainers MT
Top Premarket Gainers MT
Earnings Flash (MOTS) MOTUS GI HOLDINGS Reports Q3 Revenue $86,000 MT
Motus GI Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Motus GI's Pure-Vu EVS Gastro Used in First Procedure DJ
Motus GI Holdings, Inc. Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu®? EVS Gastro CI
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading MT
Top Premarket Gainers MT
Motus GI Holdings, Inc. Receives Fda Clearance to Commercialize Pure-Vu Evs Gastro and Gen 4 Colon CI
Motus Gi Submits Special 510(K) to Fda for Pure-Vu Evs Gen 4 Gastro and Colon CI
Motus GI Holdings, Inc. Announces Executive Changes CI
Earnings Flash (MOTS) MOTUS GI HOLDINGS Posts Q2 Revenue $113,000 MT
Motus GI Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Motus GI Holdings, Inc. Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of Its Pure-Vu® EVS System CI
Motus GI Holdings, Inc. Announces Banner Desert Medical Center Purchases and Initiates Implementation of Pure-Vu System CI
Chart Motus GI Holdings, Inc.
More charts
Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.
More about the company